GDF15 and pulmonary fibrosis: In order to determine the effect of GDF15 neutralization in vivo, we employed a bleomycin-mediated lung fibrosis model in mice and administered anti-GDF15 monoclonal antibody 14 days after initiation of injury (Figure 4A).